Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021–2031), Trend, and Growth Opportunity Analysis Coverage: By Type [Type 1 Collagen (Polymerized, Hydrolyzed, and Atelocollagen) and Hyaluronic Acid], End User (Hospitals, Orthopedic Clinics, and Others), and Country

BMIRE00030877 | Pages: 90 | Medical Device | Oct 2024 | Status: Published

The Europe intra-articular injection for osteoarticular infiltrations market size is expected to grow from US$ 97.43 million in 2023 to US$ 157.08 million by 2031; it is projected to register a CAGR of 6.2% during 2023-2031.

Intra-articular injections for osteoarthritis are a medical procedure where medication is injected directly into a joint affected by osteoarthritis. This approach is intended to reduce pain and improve joint function. Increasing awareness among healthcare professionals and patients regarding the benefits of these injections, combined with increasing investment in healthcare infrastructure and innovation, is facilitating increased access to these treatments. The increasing prevalence of osteoarthritis and advancements in injection techniques are noteworthy factors contributing to the expansion of the Europe intra-articular injection for osteoarticular infiltrations market size. However, the side effects associated with intra-articular injections hinder the Europe intra-articular injection for osteoarticular infiltrations market growth.

Intra-articular injections are among the innovative and emerging fields of treatment for osteoarticular infiltrations. Manufacturers are involved in various clinical trials to ensure the safety, efficacy, and reliability of innovative drugs. For instance, in May 2024, the Swedish Company, Synartro, initiated a capital raise of between US$ 3.73 and 7.36 million to conduct a clinical study of the osteoarthritis candidate SYN321. It is in the final phase to secure an EU grant of US$ 2.78 million. Additionally, in April 2023, the company received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to start the phase 1/2a first-in-human clinical study of the investigational drug candidate SYN321. Other market players in the regions are also conducting clinical trials for intra-articular injections, which can lead to the development of innovative products. For instance, in August 2022, Grünenthal, a German company enrolled the first patient in its global clinical Phase III program for resiniferatoxin (RTX). Grünenthal has conducted three trials in ~200 locations across Europe, the US, Latin America, South Africa, and Japan to investigate the safety and effectiveness of intra-articular injections of RTX in adults. The outcomes observed in the trials mainly focus on an improvement in the physical function and pain score in the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index from baseline to 52 weeks. Upon completion, the Phase III program is intended to provide marketing approval for RTX in Europe, the US, and Japan. The company intends to submit a new drug application in 2024, indicating the potential market entry of RTX in 2025. Therefore, the increasing number of clinical trials are expected to enhance the development of innovative products in the region, which, in turn, will contribute to the Europe intra-articular injection for osteoarticular infiltrations market growth in coming years. 

Type-Based Insights

Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is segmented into Type 1 collagen and hyaluronic acid. The hyaluronic acid segment held the largest Europe intra-articular injection for osteoarticular infiltrations market share in 2023 Hyaluronic acid injections are employed to treat knee pain in patients who were not responsive to other treatment options. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory. A robust focus on developing and introducing novel products in the market is expected to support the growth of the segment, thereby contributing to market growth.

The Centers for Disease Control and Prevention, World Health Organization, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Europe intra-articular injection for osteoarticular infiltrations market report.

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1         Hypothesis formulation:

3.2.2         Macro-economic factor analysis:

3.2.3         Developing base number:

3.2.4         Data Triangulation:

3.2.5         Country level data:

4.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape

4.1       Overview

4.2       PEST Analysis

4.3       Information on why collagen injections are better than HA injections

4.4       Pricing Analysis

5.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics

5.1       Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics

5.2       Market Drivers

5.2.1         Rising Prevalence of Osteoarthritis

5.2.2         Advancements in Injection Techniques

5.3       Market Restraints

5.3.1         Side Effects Associated with Intra-Articular Injections

5.4       Market Opportunities

5.4.1         Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations

5.5       Future Trends

5.5.1         Increasing Number of Clinical Trials

5.6       Impact of Drivers and Restraints:

6.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis

6.1       Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031

6.2       Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis

7.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by Type

7.1       Type 1 Collagen

7.1.1         Overview

7.1.2         Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

7.2       Hyaluronic Acid

7.2.1         Overview

7.2.2         Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by End User

8.1       Hospitals

8.1.1         Overview

8.1.2         Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8.2       Orthopedic Clinics

8.2.1         Overview

8.2.2         Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8.3       Others

8.3.1         Overview

8.3.2         Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Country Analysis

9.1       Europe

9.1.1         Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries

9.1.2         Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country

9.1.2.1            Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country

9.1.2.2            Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.2.1           Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.2.2           Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.2.3           Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.3            United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.3.1           United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.3.2           United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.3.3           United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.4            France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.4.1           France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.4.2           France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.4.3           France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.5            Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.5.1           Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.5.2           Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.5.3           Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.6            Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.6.1           Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.6.2           Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.6.3           Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.7            Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.7.1           Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.7.2           Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.7.3           Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.8            Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.8.1           Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.8.2           Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.8.3           Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

10.        Industry Landscape

10.1     Overview

10.2     Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

10.3     Organic Growth Strategies

10.3.1       Overview

10.4     Inorganic Growth Strategies

10.4.1       Overview

11.        Company Profiles

11.1     Bioventus Inc

11.1.1       Key Facts

11.1.2       Business Description

11.1.3       Products and Services

11.1.4       Financial Overview

11.1.5       SWOT Analysis

11.1.6       Key Developments

11.2     SEIKAGAKU CORPORATION

11.2.1       Key Facts

11.2.2       Business Description

11.2.3       Products and Services

11.2.4       Financial Overview

11.2.5       SWOT Analysis

11.2.6       Key Developments

11.3     Maxigen Biotech Inc.

11.3.1       Key Facts

11.3.2       Business Description

11.3.3       Products and Services

11.3.4       Financial Overview

11.3.5       SWOT Analysis

11.3.6       Key Developments

11.4     stem Medical Inc.

11.4.1       Key Facts

11.4.2       Business Description

11.4.3       Products and Services

11.4.4       Financial Overview

11.4.5       SWOT Analysis

11.4.6       Key Developments

11.5     Sanofi SA

11.5.1       Key Facts

11.5.2       Business Description

11.5.3       Products and Services

11.5.4       Financial Overview

11.5.5       SWOT Analysis

11.5.6       Key Developments

11.6     Ferring Pharmaceuticals

11.6.1       Key Facts

11.6.2       Business Description

11.6.3       Products and Services

11.6.4       Financial Overview

11.6.5       SWOT Analysis

11.6.6       Key Developments

11.7     Fidia Pharma USA Inc.

11.7.1       Key Facts

11.7.2       Business Description

11.7.3       Products and Services

11.7.4       Financial Overview

11.7.5       SWOT Analysis

11.7.6       Key Developments

11.8     Biotech Healthcare Group

11.8.1       Key Facts

11.8.2       Business Description

11.8.3       Products and Services

11.8.4       Financial Overview

11.8.5       SWOT Analysis

11.8.6       Key Developments

11.9     Bioteck S.p.A.

11.9.1       Key Facts

11.9.2       Business Description

11.9.3       Products and Services

11.9.4       Financial Overview

11.9.5       SWOT Analysis

11.9.6       Key Developments

11.10  I+MED

11.10.1    Key Facts

11.10.2    Business Description

11.10.3    Products and Services

11.10.4    Financial Overview

11.10.5    SWOT Analysis

11.10.6    Key Developments

12.        Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

List of Tables

Table 1.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation

Table 2.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Table 3.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 4.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 5.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 6.             Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Country

Table 7.             Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 8.             Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 9.             Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 10.          United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 11.          United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 12.          United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 13.          France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 14.          France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 15.          France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 16.          Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 17.          Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 18.          Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 19.          Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 20.          Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 21.          Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 22.          Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 23.          Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 24.          Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 25.          Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 26.          Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 27.          Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 28.          Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

Table 29.          Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market

Table 30.          Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market

List of Figures

Figure 1.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country

Figure 2.           PEST Analysis

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031

Figure 5.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by Type, 2023 and 2031

Figure 6.           Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.           Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.           Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by End User, 2023 and 2031

Figure 9.           Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.        Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.        Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.        Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 13.        Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.        United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.        France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.        Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.        Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.        Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.        Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.        Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

  • Bioventus Inc.
  • SEIKAGAKU CORPORATION
  • Maxigen Biotech Inc.
  • ?stem Medical Inc.
  • Sanofi SA
  • Ferring Pharmaceuticals
  • Fidia Pharma USA Inc.
  • Biotech Healthcare Group
  • Bioteck S.p.A.
  • I+MED.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intra-articular injection for osteoarticular infiltrations market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe intra-articular injection for osteoarticular infiltrations market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440